Cytokinetics Inc (CYTK)

Happy Stock Trading Bull Market NYSE Insider Trading hedge funds

Hedge Fund and Insider Trading News: Michael Platt, Warren Buffett, Balyasny Asset Management, AQR Capital, Aspen Group Inc (ASPU), W&T Offshore, Inc. (WTI), and More

Balyasny Gains in First Half After Losses Prompted Reorganization in 2018 (Reuters) BOSTON (Reuters) – Balyasny Asset Management, a Chicago-based......(read more)

July 15 - Hedge Funds, Insider Trading - Comments

13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)

Cytokinetics Inc (NASDAQ:CYTK): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP&#......(read more)

December 1 - Hedge Funds - Comments

13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)

May 15 - Hedge Funds - Comments

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Here’s What You Should Know About The Finance World Today

1. US Stock Market: “U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market. The Dow Jones......(read more)

April 18 - Commodities, Gold, Market Movers, News, Tech - Comments

New Changes in SAC Capital’s 13F Portfolio: Annies Inc (BNNY), Cytokinetics, Inc. (CYTK) And Other

In another round of filings with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have disclosed 4 new moves:......(read more)

April 9 - Hedge Funds, News - Comments

Mark Lampert, Biotechnology Value Fund Up Stake In Cytokinetics, Inc. (CYTK), Reduce Exposure To Regado Biosciences Inc (RGDO)

Mark Lampert, the founder and manager of Biotechnology Value Fund, is bullish on Cytokinetics, Inc. (NASDAQ:CYTK). According to a recent filing with......(read more)

March 26 - Hedge Funds, News - Comments

Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)

Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) a good investment? At the moment, there are many indicators market participants can use to......(read more)

September 17 - News - Comments

This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)

Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment......(read more)

September 17 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR): Cheers and Jeers for Amgen, Inc. (AMGN)’s Pipeline

Just after the successful acquisition of Onyx Pharmaceuticals and positive results on AMG-145, a cholesterol-lowering experimental drug, Amgen, Inc......(read more)

September 11 - News - Comments

Cytokinetics, Inc. (CYTK), Amgen, Inc. (AMGN): Digging Deeper Into This Heart Failure Drug’s Miss

Before the market opened last Tuesday, Cytokinetics, Inc. (NASDAQ:CYTK) and Amgen, Inc. (NASDAQ:AMGN) scrambled to spin the results of their Phase 2......(read more)

September 10 - News - Comments

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

Astex Pharmaceuticals, Inc. (ASTX), GlaxoSmithKline plc (ADR) (GSK), Cytokinetics, Inc. (CYTK): Last Week in Biotech

With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)

September 9 - News - Comments

MiMedx Group Inc (MDXG), Cytokinetics, Inc. (CYTK), Amgen, Inc. (AMGN): A Trio of Horrendous Health-Care Stocks This Week

College football arrived in a big way over the past week or so, with plenty of big plays already. Health-care stocks had their fair share of big plays......(read more)

September 7 - News - Comments

Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?

Should Pain Therapeutics, Inc. (NASDAQ:PTIE) investors track the following data? In the eyes of many investors, hedge funds are viewed as overrated,......(read more)

September 6 - News - Comments

What Hedge Funds Think About ArQule, Inc. (ARQL)

Is ArQule, Inc. (NASDAQ:ARQL) a good investment? In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks......(read more)

September 3 - News - Comments

Celgene Corporation (CELG), Cytokinetics, Inc. (CYTK), Astex Pharmaceuticals, Inc. (ASTX): Is the Biotech Bubble About to Burst?

“Bubble” can be a provocative word in investing circles. Think of all that comes to mind when you hear it — perhaps other words like......(read more)

August 27 - News - Comments

What’s a Smart Cytokinetics, Inc. (CYTK) Investor To Do?

What’s a smart Cytokinetics, Inc. (NASDAQ:CYTK) investor to do? In the eyes of many of your peers, hedge funds are seen as useless, old investment......(read more)

August 22 - News - Comments

Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Companies to Watch Out For

Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth......(read more)

August 3 - News - Comments

Cytokinetics, Inc. (CYTK), Exelixis, Inc. (EXEL): Three Small Cap Biotech Stocks with Great Potential

Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S. has a number of small cap stocks......(read more)

July 17 - News - Comments

Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?

Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe......(read more)

July 12 - News - Comments

OncoGenex Pharmaceuticals Inc (OGXI): Are Hedge Funds Right About This Stock?

Is OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) a cheap investment today? Money managers are getting more bullish. The number of long hedge fund bets improved......(read more)

July 8 - News - Comments

Cytokinetics, Inc. (CYTK): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds’ portfolio at the end of March. CYTK shareholders have witnessed an increase in support from......(read more)

June 24 - News - Comments

Hedge Funds Are Crazy About Cytokinetics, Inc. (CYTK)

Is Cytokinetics, Inc. (NASDAQ:CYTK) the right pick for your portfolio? Prominent investors are in a bullish mood. The number of bullish hedge fund bets......(read more)

June 17 - News - Comments

Is BioDelivery Sciences International, Inc. (BDSI) Going to Burn These Hedge Funds?

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders have witnessed a decrease in hedge fund sentiment of late; stagnant interest is a......(read more)

June 13 - News - Comments

Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?

Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood. The number of long hedge fund positions were trimmed......(read more)

June 10 - News - Comments

Amgen, Inc. (AMGN), Cytokinetics, Inc. (CYTK): A New Approach to Treating a Broken Heart

A failing heart is a lot like a glass Heinz Ketchup bottle. Squeezing the bottle isn’t very efficient, so you smack that strategically placed &#......(read more)

April 29 - News - Comments

Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?

Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident. The number of bullish hedge fund......(read more)

April 13 - News - Comments

Zynga Inc (ZNGA), Cytokinetics, Inc. (CYTK), and More: 3 Stocks That Blew the Market Away

Don’t settle for ordinary quarterly reports. Every week, I take a look at three companies that beat market expectations, since I believe that it......(read more)

February 11 - News - Comments

Posts Tagged ‘Cytokinetics Inc (CYTK)’